10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2009 | ||
Statement Of Financial Position Classified | ||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 1,272,958 | 1,459,302 |
| Short-term marketable securities | 384,017 | 330,760 |
| Accounts receivable, net of allowances of $132,810 at December 31, 2009 and $90,694 at December 31, 2008 | 1,389,534 | 1,023,397 |
| Inventories | 1,051,771 | 927,868 |
| Deferred tax assets | 295,080 | 140,882 |
| Prepaid taxes | 274,196 | 198,318 |
| Prepaid expenses | 78,111 | 71,815 |
| Other current assets | 66,891 | 126,066 |
| Total current assets | 4,812,558 | 4,278,408 |
| Property, plant and equipment, net | 699,970 | 528,799 |
| Noncurrent portion of prepaid royalties | 226,250 | 257,208 |
| Noncurrent deferred tax assets | 101,498 | 226,728 |
| Long-term marketable securities | 2,247,871 | 1,449,577 |
| Intangible assets | 1,524,777 | 123,008 |
| Other noncurrent assets | 85,635 | 73,103 |
| Total assets | 9,698,559 | 6,936,831 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | 810,544 | 601,200 |
| Accrued government rebates | 248,660 | 176,939 |
| Accrued compensation and employee benefits | 132,481 | 103,840 |
| Income taxes payable | 167,623 | 44,757 |
| Other accrued liabilities | 384,015 | 245,662 |
| Deferred revenues | 122,721 | 42,963 |
| Current portion of other long-term obligations | 5,587 | 5,631 |
| Total current liabilities | 1,871,631 | 1,220,992 |
| Long-term deferred revenues | 43,026 | 74,181 |
| Convertible senior notes, net | 1,155,443 | 1,098,025 |
| Long-term income taxes payable | 87,383 | 56,588 |
| Other long-term obligations | 35,918 | 21,462 |
| Commitments and contingencies (Note 11) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.001 per share; 5,000 shares authorized; none outstanding | 0 | 0 |
| Common stock, par value $0.001 per share; 2,800,000 shares authorized; 899,753 and 909,819 shares issued and outstanding at December 31, 2009 and 2008, respectively | 900 | 910 |
| Additional paid-in capital | 4,376,651 | 3,930,109 |
| Accumulated other comprehensive income (loss) | (5,758) | 41,240 |
| Retained earnings | 1,995,272 | 300,314 |
| Total Gilead stockholders' equity | 6,367,065 | 4,272,573 |
| Noncontrolling interest | 138,093 | 193,010 |
| Total stockholders' equity | 6,505,158 | 4,465,583 |
| Total liabilities and stockholders' equity | 9,698,559 | 6,936,831 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |